Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
TGF-β increased (P = 0.012); IL-17 increase prevented (P = 0.039); vitamin D level correlated with TGF-β (r = 0.306, P = 0.008)
Source: Study selection. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Serum inflammatory cytokines as biomarkers for predicting chronic migraine transformation: a systematic review of randomized controlled trials
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Serum inflammatory cytokines as biomarkers for predicting chronic migraine transformation: a systematic review of randomized controlled trials
Systematic review · Annals of Medicine and Surgery · 2025
Original publication title
Serum inflammatory cytokines as biomarkers for predicting chronic migraine transformation: a systematic review of randomized controlled trials
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Chronic migraine (CM), defined as ≥15 headache days per month, often evolves from episodic migraine. Inflammation is implicated in migraine pathogenesis, and elevated pro-inflammatory cytokines may serve as biomarkers for predicting chronification. This systematic review evaluates randomized controlled trials (RCTs) assessing serum cytokines in migraine patients to explore their potential predictive and therapeutic relevance.
Source: Background:Abstract: What methods does the paper describe?
A systematic search of PubMed, Scopus, Web of Science, and clinical trial registries (to October 2024) identified English-language RCTs reporting serum cytokine levels in migraine patients. Included studies measured inflammatory cytokines [e.g., interleukins, TNF-α, and C-reactive protein (CRP)] and related them to migraine frequency or transformation. Two reviewers screened studies and extracted data on cytokine outcomes and migraine progression. Risk of bias was assessed using the Cochrane RoB 2.0 tool.
Source: Methods:Abstract: Results
Nine RCTs (n ≈ 445) met inclusion criteria. Pro-inflammatory cytokines evaluated included IL-6, IL-1β, IL-17A, TNF-α, and CRP, while some trials also assessed anti-inflammatory markers (IL-4, IL-10, and TGF-β). Several trials involved interventions (omega-3 fatty acids, curcumin, probiotics, or exercise) and reported that reductions in pro-inflammatory cytokines corresponded with decreased migraine frequency. Notably, combination nutraceutical therapies (e.g., omega-3 plus nano-curcumin) led to significant declines in IL-1β, IL-6, and TNF-α, along with fewer migraine attacks. Aerobic exercise reduced IL-12p70 and headache days.
In contrast, probiotic therapy improved symptoms without consistent cytokine changes. Although none of the RCTs were explicitly designed to predict CM transformation, patients with higher baseline cytokine levels tended to have more frequent migraines and showed stronger inflammatory modulation after treatment.
Source: Results:Abstract: Conclusions
Elevated pro-inflammatory cytokines are frequently observed in patients with frequent or CM and may signal increased risk of progression. Their modulation through anti-inflammatory interventions aligns with clinical improvement, suggesting that these cytokines may function as both biomarkers and therapeutic targets. Larger, longitudinal RCTs are needed to confirm their predictive value and utility in preventing migraine chronification through early inflammatory profiling.
Source: Conclusions:Authors’ abstract
Background:
Chronic migraine (CM), defined as ≥15 headache days per month, often evolves from episodic migraine. Inflammation is implicated in migraine pathogenesis, and elevated pro-inflammatory cytokines may serve as biomarkers for predicting chronification. This systematic review evaluates randomized controlled trials (RCTs) assessing serum cytokines in migraine patients to explore their potential predictive and therapeutic relevance.
Methods:
A systematic search of PubMed, Scopus, Web of Science, and clinical trial registries (to October 2024) identified English-language RCTs reporting serum cytokine levels in migraine patients. Included studies measured inflammatory cytokines [e.g., interleukins, TNF-α, and C-reactive protein (CRP)] and related them to migraine frequency or transformation. Two reviewers screened studies and extracted data on cytokine outcomes and migraine progression. Risk of bias was assessed using the Cochrane RoB 2.0 tool.
Results:
Nine RCTs (n ≈ 445) met inclusion criteria. Pro-inflammatory cytokines evaluated included IL-6, IL-1β, IL-17A, TNF-α, and CRP, while some trials also assessed anti-inflammatory markers (IL-4, IL-10, and TGF-β). Several trials involved interventions (omega-3 fatty acids, curcumin, probiotics, or exercise) and reported that reductions in pro-inflammatory cytokines corresponded with decreased migraine frequency. Notably, combination nutraceutical therapies (e.g., omega-3 plus nano-curcumin) led to significant declines in IL-1β, IL-6, and TNF-α, along with fewer migraine attacks. Aerobic exercise reduced IL-12p70 and headache days.
In contrast, probiotic therapy improved symptoms without consistent cytokine changes. Although none of the RCTs were explicitly designed to predict CM transformation, patients with higher baseline cytokine levels tended to have more frequent migraines and showed stronger inflammatory modulation after treatment.
Conclusions:
Elevated pro-inflammatory cytokines are frequently observed in patients with frequent or CM and may signal increased risk of progression. Their modulation through anti-inflammatory interventions aligns with clinical improvement, suggesting that these cytokines may function as both biomarkers and therapeutic targets. Larger, longitudinal RCTs are needed to confirm their predictive value and utility in preventing migraine chronification through early inflammatory profiling.
Publication and source details
Original title: Serum inflammatory cytokines as biomarkers for predicting chronic migraine transformation: a systematic review of randomized controlled trials
Ebad Ur Rehman Syed; Nissan Nazar; Nalla Jaipal Reddy
Annals of Medicine and Surgery · 2025
* Corresponding author. Address: Neurology, VN Karazina Kharkiv National University, Kharkiv 61022, Ukraine. Tel.: +91-9154045934. E-mail: jaipalreddy1996@gmail.com (N.J. Reddy).Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.2025https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T02:08:02.234707+00:00
DOI: 10.1097/ms9.0000000000004121 · PMC12688845